The Prosserman Centre for Population Health Research (PCPHR) was established in March 2003, as part of the Lunenfeld-Tanenbaum Research Institute, Sinai Health System. It comprised of a group of scientists with expertise in quantitative research of complex diseases, including cancer, diabetes, and cardiovascular diseases, using a population health approach. The overall goal of PCPHR research is to reduce disease burden and improve population health through understanding the etiology, early detection, and prognosis of chronic health conditions.
As part of the continuum of complex diseases, the group also has a focus on research related to Developmental Origins of Health and Disease in collaboration with several birth cohorts in Canada, Europe and Asia. Collectively, the group has extensive expertise and experience in epidemiology, biostatistics and machine learning methods including multi-omics studies for complex diseases and traits. This expertise involves analytical methodology development and innovative applications to clinical translation. The scope of the research in PCPHR encompasses large-scale epidemiological studies with deep phenotyping, genomic discovery, statistical modeling of disease risk and progression and clinical trials.
The research in the Prosserman Centre for Population Health Research is supported by the following: US National Institutes of Health (NIH), Canadian Institutes for Health Research (CIHR), Canadian Cancer Society Research Institute(CCSRI), March of Dimes, Alex's Lemonade Stand Foundation for Childhood Cancer, Ontario Ministry of Health, Natural Sciences and Engineering Research Council (NSERC), University of Toronto McLaughlin Centre, MITACS, Canadian Statistical Sciences Institute, Prostate Cancer Canada, Canadian Foundation for Innovation(CFI) and more.
